JPRN-UMIN000029843已完成未知
Sirolimus for the treatment of refractory lymphangiomatosis/ Gorham Stout disease - Sirolimus for the treatment of refractory lymphangiomatosis/ Gorham Stout disease
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 2
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 8years-old 至 30years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Allergy of sirolimus
研究者
相似试验
已完成
1 期
Sirolimus for the treatment of lymphangiomatosis, Gorham-Stout disease and vascular anomaliesymphangiomatosis, Gorham-Stout disease and vascular anomaliesJPRN-UMIN000016580Gifu university30
进行中（未招募）
不适用
Sirolimus (Rapamune®) for the treatment of anti-Hu associated paraneoplastic neurological syndromes - Sirolimus for Hu-PNSParaneoplastic Neurological Syndromes associated with anti-Hu antibodiesMedDRA version: 9.1Level: LLTClassification code 10014619Term: EncephalomyelitisEUCTR2008-000793-20-NLErasmus MC
已完成
2 期
Sirolimus (Rapamune®) for the treatment of anti-Hu associated paraneoplastic neurological syndromesParaneoplasiaremote effect of cancer1000381610007951NL-OMON32182Erasmus MC, Universitair Medisch Centrum Rotterdam17
招募中
不适用
Efficacy and safety of low dose sirolimus in lymphangioleiomyomatosislymphangioleiomyomatosisJPRN-UMIN000016677ational Hospital Organization Kinki-chuo Chest Medical Center20
已完成
1 期
Everolimus for the treatment of lymphangiomatosis, Gorham-Stout disease and vascular anomaliesymphangiomatosis, Gorham-Stout disease and vascular anomaliesJPRN-UMIN000014888Gifu university30